Cargando…

Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020

Detalles Bibliográficos
Autores principales: Shahriar, Arman A., Vazquez Benitez, Gabriela, Pawloski, Pamala A., Dehmer, Steven P., Alpern, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086023/
https://www.ncbi.nlm.nih.gov/pubmed/34047918
http://dx.doi.org/10.1007/s11606-021-06838-x
_version_ 1784703931737178112
author Shahriar, Arman A.
Vazquez Benitez, Gabriela
Pawloski, Pamala A.
Dehmer, Steven P.
Alpern, Jonathan D.
author_facet Shahriar, Arman A.
Vazquez Benitez, Gabriela
Pawloski, Pamala A.
Dehmer, Steven P.
Alpern, Jonathan D.
author_sort Shahriar, Arman A.
collection PubMed
description
format Online
Article
Text
id pubmed-9086023
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-90860232022-05-11 Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020 Shahriar, Arman A. Vazquez Benitez, Gabriela Pawloski, Pamala A. Dehmer, Steven P. Alpern, Jonathan D. J Gen Intern Med Concise Research Report Springer International Publishing 2021-05-28 2022-05 /pmc/articles/PMC9086023/ /pubmed/34047918 http://dx.doi.org/10.1007/s11606-021-06838-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Concise Research Report
Shahriar, Arman A.
Vazquez Benitez, Gabriela
Pawloski, Pamala A.
Dehmer, Steven P.
Alpern, Jonathan D.
Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
title Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
title_full Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
title_fullStr Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
title_full_unstemmed Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
title_short Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
title_sort characteristics of state legislation addressing prescription drug price increases in the united states, 2020
topic Concise Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086023/
https://www.ncbi.nlm.nih.gov/pubmed/34047918
http://dx.doi.org/10.1007/s11606-021-06838-x
work_keys_str_mv AT shahriararmana characteristicsofstatelegislationaddressingprescriptiondrugpriceincreasesintheunitedstates2020
AT vazquezbenitezgabriela characteristicsofstatelegislationaddressingprescriptiondrugpriceincreasesintheunitedstates2020
AT pawloskipamalaa characteristicsofstatelegislationaddressingprescriptiondrugpriceincreasesintheunitedstates2020
AT dehmerstevenp characteristicsofstatelegislationaddressingprescriptiondrugpriceincreasesintheunitedstates2020
AT alpernjonathand characteristicsofstatelegislationaddressingprescriptiondrugpriceincreasesintheunitedstates2020